Drug intelligence / Profile preview

Cancer VITA

Development stage: Preclinical
Lead developer: Cannabis Bioscience International
Modality: Small Molecules

Overview

Cancer VITA is a cannabinoid formulation developed by Cannabis Bioscience International Holdings (CBIH) as a nutraceutical product. It is currently undergoing clinical data collection to evaluate its safety and efficacy, with funding and strategic support provided by VITA Biotech Research. The product is also undergoing trademark registration, and its manufacturing and distribution are facilitated through a partnership with Stephen Gould.

Brand names: Cancer VITA

Beyond the preview

Go deeper on Cancer VITA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer VITA.

Explore the full profile